These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
204 related articles for article (PubMed ID: 31975156)
21. Clinical implementation of PLANET® Dose for dosimetric assessment after [ Santoro L; Pitalot L; Trauchessec D; Mora-Ramirez E; Kotzki PO; Bardiès M; Deshayes E EJNMMI Res; 2021 Jan; 11(1):1. PubMed ID: 33394212 [TBL] [Abstract][Full Text] [Related]
22. Is a single late SPECT/CT based kidney Beykan S; Tran-Gia J; Borup Jensen S; Lassmann M Phys Med; 2022 Aug; 100():39-50. PubMed ID: 35724608 [TBL] [Abstract][Full Text] [Related]
23. Non-Invasive Imaging Methodologies for Assessment of Radiation Damage to Bone Marrow and Kidneys from Peptide Receptor Radionuclide Therapy. Ahlstedt J; Johansson E; Sydoff M; Karlsson H; Thordarson E; Gram M; Eriksson O Neuroendocrinology; 2020; 110(1-2):130-138. PubMed ID: 30999299 [TBL] [Abstract][Full Text] [Related]
24. Effect of image registration on 3D absorbed dose calculations in Grassi E; Fioroni F; Berenato S; Patterson N; Ferri V; Braglia L; Filice A; Versari A; Iori M; Spezi E Phys Med; 2018 Jan; 45():177-185. PubMed ID: 29472084 [TBL] [Abstract][Full Text] [Related]
25. Single-time-point estimation of absorbed doses in PRRT using a non-linear mixed-effects model. Hardiansyah D; Riana A; Beer AJ; Glatting G Z Med Phys; 2023 Feb; 33(1):70-81. PubMed ID: 35961809 [TBL] [Abstract][Full Text] [Related]
26. Safety, Pharmacokinetics, and Dosimetry of a Long-Acting Radiolabeled Somatostatin Analog Zhang J; Wang H; Jacobson O; Cheng Y; Niu G; Li F; Bai C; Zhu Z; Chen X J Nucl Med; 2018 Nov; 59(11):1699-1705. PubMed ID: 29653971 [TBL] [Abstract][Full Text] [Related]
27. An International Study of Factors Affecting Variability of Dosimetry Calculations, Part 2: Overall Variabilities in Absorbed Dose. Brosch-Lenz J; Ke S; Wang H; Frey E; Dewaraja YK; Sunderland J; Uribe C J Nucl Med; 2023 Jul; 64(7):1109-1116. PubMed ID: 37024302 [TBL] [Abstract][Full Text] [Related]
28. Implementation of patient dosimetry in the clinical practice after targeted radiotherapy using [ Santoro L; Mora-Ramirez E; Trauchessec D; Chouaf S; Eustache P; Pouget JP; Kotzki PO; Bardiès M; Deshayes E EJNMMI Res; 2018 Nov; 8(1):103. PubMed ID: 30498938 [TBL] [Abstract][Full Text] [Related]
29. A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy (PRRT): 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods. Belli ML; Mezzenga E; Di Iorio V; Celli M; Caroli P; Canali E; Matteucci F; Tardelli E; Grassi I; Sansovini M; Nicolini S; Severi S; Cremonesi M; Ferrari M; Paganelli G; Sarnelli A J Vis Exp; 2020 Apr; (158):. PubMed ID: 32391816 [TBL] [Abstract][Full Text] [Related]
30. Impact of dead time on quantitative Desy A; Bouvet GF; Frezza A; Després P; Beauregard JM EJNMMI Phys; 2020 May; 7(1):32. PubMed ID: 32415492 [TBL] [Abstract][Full Text] [Related]
31. Early prediction of tumour response to PRRT. The sequential change of tumour-absorbed doses during treatment with 177Lu-octreotate. Ezziddin S; Reichmann K; Yong-Hing C; Damm M; Risse J; Ahmadzadehfar H; Logvinski T; Guhlke S; Biersack HJ; Sabet A Nuklearmedizin; 2013; 52(5):170-7. PubMed ID: 23963021 [TBL] [Abstract][Full Text] [Related]
32. Prospective observational study of Garske-Román U; Sandström M; Fröss Baron K; Lundin L; Hellman P; Welin S; Johansson S; Khan T; Lundqvist H; Eriksson B; Sundin A; Granberg D Eur J Nucl Med Mol Imaging; 2018 Jun; 45(6):970-988. PubMed ID: 29497803 [TBL] [Abstract][Full Text] [Related]